close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

579.89 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Madrigal Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Singing Machine, Blue Apron, Camber Energy And More Short Squeeze Candidates That Could Soar This Week ↗
Potential short squeeze plays gained steam in 2021 and have continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common... 
Via Benzinga
News headline image
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023 ↗
Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results. 
Via The Motley Fool
News headline image
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,800 Today ↗
 
Via Benzinga
News headline image
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review ↗
The market uptrend is under pressure. 
Via Investor's Business Daily
Analyst Ratings for Madrigal Pharmaceuticals ↗
 
Via Benzinga
News headline image
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector ↗
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Why Madrigal Pharmaceuticals Was a Top Stock This Week ↗
Biotech bulls stampeded the company following its latest clinical update. 
Via The Motley Fool
News headline image
7 Drug Stocks That Will Soar in 2023 ↗
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
Via InvestorPlace
News headline image
Earnings Optimism Puts Wind In Wall Street's Sails ↗
The major indexes are extending their rally off a mid-December losing streak. 
Via Talk Markets
News headline image
Why Did Viking Therapeutics Stock Skyrocket
VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. 
Via MarketBeat
News headline image
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says ↗
 
Via Benzinga
News headline image
Madrigal Pharmaceuticals Gets Price Target Bumps By Analysts Following Successful NASH Study ↗
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. Madrigal Pharmaceuticals shares jumped 268.1% to close... 
Via Benzinga
News headline image
Peering Into Madrigal Pharmaceuticals's Recent Short Interest ↗
Madrigal Pharmaceuticals's (NASDAQ:MDGL) short percent of float has risen 3.82% since its last report. The company recently reported that it has 2.16 million shares sold short, which is 15.49% of all... 
Via Benzinga
News headline image
Tesla To $285? Here Are 10 Other Price Target Changes For Tuesday ↗
Wells Fargo raised Ross Stores, Inc. (NASDAQ: ROST) price target from $120 to $135. Wells Fargo analyst Ike Boruchow maintained an Overweight rating on the stock. Ross Stores shares fell 0.9% to close... 
Via Benzinga
News headline image
Here's How An Options Trader Made $5.5 Million In One Day ↗
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) shares rose sharply on Monday after the company announced positive topline results from the pivotal Phase 3 MAESTRO-NASH (fatty liver disease) 
Via Benzinga
News headline image
Tesla, Amazon, Apple, Madrigal, Walt Disney: Why These 5 Stocks Are Drawing Investors' Attention Today ↗
Major Wall Street indices closed in the red on Monday as investor optimism on the much-anticipated Santa Claus rally began to fade over fears of recession gaining momentum. 
Via Benzinga
News headline image
Healthcare Portfolio Is Doing Well But Biotech Stocks Are Mired In Macro ↗
The biotech sector has not done well in 2022 despite some strong runs. Small and mid-cap stocks are more “risk-off’ with interest rates rising and sentiment waning. 
Via Talk Markets
News headline image
Madrigal Pharmaceuticals (NASDAQ: MDGL) Reports Impressive Topline Results from Phase 3 Trial of Resmetirom to Treat NASH and Liver Fibrosis
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development 
Via Spotlight Growth
News headline image
Dow Struggles To Maintain Morning Gains ↗
This morning's rally was short-lived, and by midday, the major indexes were trading back in the red amid looming recession anxieties. 
Via Talk Markets
News headline image
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Madrigal Pharmaceuticals Stock Is Crushing It Today ↗
The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic steatohepatitis) drug. 
Via The Motley Fool
News headline image
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning ↗
Good news can come in different forms. 
Via The Motley Fool
News headline image
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today? ↗
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company. 
Via InvestorPlace
News headline image
AJRD Stock Alert: What to Know as L3Harris Technologies Acquires Aerojet Rocketdyne ↗
Aerojet Rocketdyne (AJRD) stock is on the move today as investors react to a $4.7 billion deal with L3Harris Technologies (LHX). 
Via InvestorPlace
News headline image
Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why
Madrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it. 
Via MarketBeat
News headline image
Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today ↗
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc 
Via Benzinga
News headline image
Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today? ↗
Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment. 
Via InvestorPlace
News headline image
Madrigal Pharma Stock Triples After Knocking NASH Study Out Of The Park ↗
The company hit both of its goals in a Phase 3 study of a pill for the liver disease. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today